• ქართული
  • English
  • Johnson & Johnson posts 23% rise in third-quarter profit

    Johnson & Johnson on Tuesday posted a 22.9% rise in third-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.

    Market Quotes by TradingView